{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T15:15:25Z","timestamp":1790176525526,"version":"4.1.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:00:00Z","timestamp":1707523200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:00:00Z","timestamp":1707523200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Ganzhou Municipal Health Commission of Jiangxi Province","award":["2020-2-43"],"award-info":[{"award-number":["2020-2-43"]}]},{"DOI":"10.13039\/100017712","name":"Bureau of Science and Technology of Ganzhou Municipality","doi-asserted-by":"publisher","award":["GZ2020ZSF179"],"award-info":[{"award-number":["GZ2020ZSF179"]}],"id":[{"id":"10.13039\/100017712","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017712","name":"Bureau of Science and Technology of Ganzhou Municipality","doi-asserted-by":"publisher","award":["GZ2020ZSF180"],"award-info":[{"award-number":["GZ2020ZSF180"]}],"id":[{"id":"10.13039\/100017712","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Jiangxi Provincial Bureau of Traditional Chinese Medicine","award":["2020B0117"],"award-info":[{"award-number":["2020B0117"]}]},{"name":"Jiangxi Provincial Bureau of Traditional Chinese Medicine","award":["2023A0198"],"award-info":[{"award-number":["2023A0198"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1007\/s10620-023-08258-9","type":"journal-article","created":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T12:02:06Z","timestamp":1707566526000},"page":"978-988","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Effectiveness and Safety of Tenofovir Alafenamide Fumarate in the Prevention of Perinatal Hepatitis B Transmission: A Meta-Analysis"],"prefix":"10.1007","volume":"69","author":[{"given":"Ji","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kangxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunping","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1872-7462","authenticated-orcid":false,"given":"Youshun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,10]]},"reference":[{"key":"8258_CR1","doi-asserted-by":"publisher","first-page":"2826","DOI":"10.1016\/j.cgh.2021.12.012","volume":"20","author":"QL Zeng","year":"2022","unstructured":"Zeng QL, Zhang HX, Zhang JY, Huang S, Li WZ, Li GM et al. Tenofovir Alafenamide for Pregnant Chinese Women With Active Chronic Hepatitis B: A Multicenter Prospective Study. Clin Gastroenterol Hepatol 2022;20:2826-2837.e2829.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"8258_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12072-015-9675-4","volume":"10","author":"SK Sarin","year":"2016","unstructured":"Sarin SK, Kumar M, Lau GK, Abbas Z, Chan HLY, Chen CJ et al. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hepatol Int 2016;10:1\u201398.","journal-title":"Hepatol Int"},{"issue":"67","key":"8258_CR3","first-page":"370","volume":"2017","author":"Liver EAftSotLEaeeeEAftSot","year":"2017","unstructured":"Liver EAftSotLEaeeeEAftSot. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol 2017;2017:370\u2013398.","journal-title":"J Hepatol"},{"key":"8258_CR4","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/cld.728","volume":"12","author":"NA Terrault","year":"2018","unstructured":"Terrault NA, Lok ASF, McMahon BJ, Chang KM, Hwang JP, Jonas MM et al. Update on Prevention, Diagnosis, and Treatment of Chronic Hepatitis B: AASLD 2018 Hepatitis B Guidance. Clin Liver Dis (Hoboken) 2018;12:33\u201334.","journal-title":"Clin Liver Dis (Hoboken)"},{"key":"8258_CR5","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1111\/apt.16043","volume":"52","author":"Y Ding","year":"2020","unstructured":"Ding Y, Cao L, Zhu L, Huang Y, Lin C, Wang Y et al. Efficacy and safety of tenofovir alafenamide fumarate for preventing mother-to-child transmission of hepatitis B virus: a national cohort study. Aliment Pharmacol Ther 2020;52:1377\u20131386.","journal-title":"Aliment Pharmacol Ther"},{"key":"8258_CR6","doi-asserted-by":"publisher","first-page":"E3324","DOI":"10.1093\/cid\/ciaa1939","volume":"73","author":"QL Zeng","year":"2021","unstructured":"Zeng QL, Yu ZJ, Ji FP, Li GM, Zhang GF, Xu JH et al. Tenofovir Alafenamide to Prevent Perinatal Hepatitis B Transmission: A Multicenter, Prospective. Observational Study. Clinical Infectious Diseases 2021;73:E3324\u2013E3332.","journal-title":"Observational Study. Clinical Infectious Diseases"},{"key":"8258_CR7","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1111\/jvh.12834","volume":"25","author":"Y Hu","year":"2018","unstructured":"Hu Y, Xu C, Xu B, Hu L, Liu Q, Chen J et al. Safety and efficacy of telbivudine in late pregnancy to prevent mother-to-child transmission of hepatitis B virus: A multicenter prospective cohort study. J Viral Hepat 2018;25:429\u2013437.","journal-title":"J Viral Hepat"},{"key":"8258_CR8","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.14218\/JCTH.2022.00047","volume":"10","author":"Z Liu","year":"2022","unstructured":"Liu Z, Chen Z, Cui F, Ding Y, Gao Y, Han G et al. Management Algorithm for Prevention of Mother-to-child Transmission of Hepatitis B Virus (2022). J Clin Transl Hepatol 2022;10:1004\u20131010.","journal-title":"J Clin Transl Hepatol"},{"key":"8258_CR9","unstructured":"Chinese Foundation for Hepatitis Prevention and Control; Chinese Society of Infectious Diseases CMACSoH, Chinese Medical Association. [Management algorithm for interrupting mother-to-child transmission of hepatitis B]. Zhonghua Gan Zang Bing Za Zhi 2017; 25: 254\u2013256."},{"key":"8258_CR10","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1111\/apt.17040","volume":"56","author":"T Kayes","year":"2022","unstructured":"Kayes T, Crane H, Symonds A, Dumond J, Cottrell M, Di Girolamo J et al. Plasma and breast milk pharmacokinetics of tenofovir alafenamide in mothers with chronic hepatitis B infection. Aliment Pharmacol Ther 2022;56:510\u2013518.","journal-title":"Aliment Pharmacol Ther"},{"key":"8258_CR11","doi-asserted-by":"crossref","unstructured":"Han G, Zhou G, Sun T, Luo X, Xu J, Chen C et al. Tenofovir alafenamide in blocking mother-to-child transmission of hepatitis B virus: a multi-center, prospective study. J Matern Fetal Neonatal Med 2022; 1\u20138.","DOI":"10.1080\/14767058.2022.2134771"},{"key":"8258_CR12","doi-asserted-by":"crossref","unstructured":"Chen RC, Zou J, Long LY et al. Safety and Efficacy of Tenofovir Alafenamide Fumarate in Early-Middle Pregnancy for Mothers With Chronic Hepatitis B. Frontiers in Medicine 2022; 8.","DOI":"10.3389\/fmed.2021.796901"},{"key":"8258_CR13","doi-asserted-by":"crossref","first-page":"16A","DOI":"10.1002\/hep.31195","volume":"72","author":"Y Ding","year":"2020","unstructured":"Ding Y, Cao L, Zhu L, Huang H, Zhang M, Fan X et al. Tenofovir alafenamide fumarate therapy for the prevention of hepatitis b vertical transmission in highly viremic mothers with chronic hepatitis B. Hepatology 2020;72:16A-17A.","journal-title":"Hepatology"},{"key":"8258_CR14","doi-asserted-by":"crossref","unstructured":"Cumpston M, Li T, Page MJ, Chandler J, Welch VA, Higgins JP et al. Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Database Syst Rev 2019; 10: Ed000142.","DOI":"10.1002\/14651858.ED000142"},{"key":"8258_CR15","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.gastrohep.2022.05.014","volume":"46","author":"J Huang","year":"2023","unstructured":"Huang J, Liu Y, Liu Y. Antiviral therapy in hepatitis B virus-infected with immune-tolerant: A meta-analysis. Gastroenterol Hepatol 2023;46:309\u2013318.","journal-title":"Gastroenterol Hepatol"},{"key":"8258_CR16","doi-asserted-by":"publisher","first-page":"S272","DOI":"10.1016\/S0168-8278(22)00913-8","volume":"77","author":"Y Zhu","year":"2022","unstructured":"Zhu Y, Wang J, Wang M, Zhou X, Zhang S, Zhang S et al. The Comparison of tenofovir alafenamide fumarate with tenofovir disoproxil fumarate in preventing hepatitis B transmission in mothers with high viral load: a retrospective cohort study. Journal of Hepatology 2022;77:S272.","journal-title":"Journal of Hepatology"},{"key":"8258_CR17","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1007\/s12072-021-10235-1","volume":"15","author":"BJ Li","year":"2021","unstructured":"Li BJ, Liu ZZ, Liu X, Liu DC, Duan MY, Gu Y et al. Efficacy and safety of tenofovir disoproxil fumarate and tenofovir alafenamide fumarate in preventing HBV vertical transmission of high maternal viral load. Hepatology International 2021;15:1103\u20131108.","journal-title":"Hepatology International"},{"key":"8258_CR18","unstructured":"YU Haiping YH. Observation on the Effect of Propofol Tenofovir Combined with Hepatitis Bimmunoglobulin on Blocking Mother-infant Transmission of Pregnant Women with High Load of Hepatitis B Virus. Drugs and Clinic 2020; 17: 47-49,62."},{"key":"8258_CR19","first-page":"131","volume":"30","author":"Chinese Society of Hepatology CMA","year":"2022","unstructured":"Chinese Society of Hepatology CMA. Expert opinion on expanding anti-HBV treatment for chronic hepatitis B. Zhonghua Gan Zang Bing Za Zhi 2022;30:131\u2013136.","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"8258_CR20","doi-asserted-by":"crossref","unstructured":"Li Z, Xie B, Yi N Cai H, Yi W, Gao X. Efficacy and safety of tenofovir disoproxil fumarate or telbivudine used throughout pregnancy for the prevention of mother-to-child transmission of hepatitis B virus: A cohort study. Eur J Obstet Gynecol Reprod Biol 2022; 276: 102\u2013106.","DOI":"10.1016\/j.ejogrb.2022.07.009"},{"key":"8258_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/rmv.2216","volume":"31","author":"ED Zeleke","year":"2021","unstructured":"Zeleke ED, Assefa DG, Joseph M, Bekele D, Tesfahunei HA, Getachew E et al. Tenofovir disoproxil fumarate for prevention of mother-to-child transmission of hepatitis B virus: A systematic review and meta-analysis of randomised control trials. Rev Med Virol 2021;31:1\u201316.","journal-title":"Rev Med Virol"},{"key":"8258_CR22","doi-asserted-by":"crossref","unstructured":"Nishijima T, Kurosawa T, Tanaka, Kawasaki Y, Kikuchi Y, Oka S N et al. Urinary \u03b22 microglobulin can predict tenofovir disoproxil fumarate-related renal dysfunction in HIV-1-infected patients who initiate tenofovir disoproxil fumarate-containing antiretroviral therapy. Aids 2016; 30: 1563\u20131571.","DOI":"10.1097\/QAD.0000000000001070"},{"key":"8258_CR23","doi-asserted-by":"publisher","first-page":"e992","DOI":"10.1097\/MEG.0000000000001977","volume":"33","author":"M Atef","year":"2021","unstructured":"Atef M, Zayed N, Salama R, Abdel Alem S, Yousof H, Saber M et al. Is urinary \u03b22-microglobulin a reliable marker for assessment of renal tubular dysfunction in chronic hepatitis B patients receiving tenofovir therapy? Eur J Gastroenterol Hepatol 2021;33:e992\u2013e998.","journal-title":"Eur J Gastroenterol Hepatol"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-023-08258-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-023-08258-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-023-08258-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,23]],"date-time":"2024-03-23T14:07:39Z","timestamp":1711202859000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-023-08258-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,10]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["8258"],"URL":"https:\/\/doi.org\/10.1007\/s10620-023-08258-9","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,10]]},"assertion":[{"value":"14 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}